ZK INTERNATIONAL GROUP CO LT (ZKIN)

VGG9892K1003 - Common Stock

0.6468  0 (-0.45%)

Fundamental Rating

1

ZKIN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. Both the profitability and financial health of ZKIN have multiple concerns. ZKIN does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

ZKIN had negative earnings in the past year.
ZKIN had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ZKIN reported negative operating cash flow in multiple years.

1.2 Ratios

ZKIN has a Return On Assets of -79.62%. This is amonst the worse of the industry: ZKIN underperforms 95.51% of its industry peers.
With a Return On Equity value of -216.36%, ZKIN is not doing good in the industry: 93.59% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -79.62%
ROE -216.36%
ROIC N/A
ROA(3y)-37.22%
ROA(5y)-20.45%
ROE(3y)-84.98%
ROE(5y)-47.62%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZKIN has a worse Gross Margin (1.29%) than 64.10% of its industry peers.
ZKIN's Gross Margin has declined in the last couple of years.
ZKIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.29%
GM growth 5Y-48.9%

2

2. Health

2.1 Basic Checks

ZKIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZKIN has more shares outstanding
ZKIN has more shares outstanding than it did 5 years ago.
ZKIN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.98, we must say that ZKIN is in the distress zone and has some risk of bankruptcy.
ZKIN has a worse Altman-Z score (0.98) than 72.44% of its industry peers.
ZKIN has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
ZKIN's Debt to Equity ratio of 0.44 is on the low side compared to the rest of the industry. ZKIN is outperformed by 73.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACCN/A
WACC8.85%

2.3 Liquidity

A Current Ratio of 1.55 indicates that ZKIN should not have too much problems paying its short term obligations.
ZKIN's Current ratio of 1.55 is on the low side compared to the rest of the industry. ZKIN is outperformed by 73.72% of its industry peers.
A Quick Ratio of 1.22 indicates that ZKIN should not have too much problems paying its short term obligations.
ZKIN has a Quick ratio (1.22) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.22

2

3. Growth

3.1 Past

The earnings per share for ZKIN have decreased strongly by -837.70% in the last year.
Looking at the last year, ZKIN shows a small growth in Revenue. The Revenue has grown by 5.20% in the last year.
Measured over the past years, ZKIN shows a quite strong growth in Revenue. The Revenue has been growing by 15.24% on average per year.
EPS 1Y (TTM)-837.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-741.76%
Revenue 1Y (TTM)5.2%
Revenue growth 3Y8.74%
Revenue growth 5Y15.24%
Sales Q2Q%6.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZKIN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZKIN!.
Industry RankSector Rank
Dividend Yield N/A

ZK INTERNATIONAL GROUP CO LT

NASDAQ:ZKIN (12/20/2024, 8:00:02 PM)

0.6468

0 (-0.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-01 2024-10-01
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner Change-13.54%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.38M
Analysts0
Price TargetN/A
Short Float %1.18%
Short Ratio2.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.82
P/tB 0.87
EV/EBITDA N/A
EPS(TTM)-1.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.18
BVpS0.79
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -79.62%
ROE -216.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.29%
FCFM N/A
ROA(3y)-37.22%
ROA(5y)-20.45%
ROE(3y)-84.98%
ROE(5y)-47.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.29%
GM growth 5Y-48.9%
F-ScoreN/A
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.22
Altman-Z 0.98
F-ScoreN/A
WACC8.85%
ROIC/WACCN/A
Cap/Depr(3y)193.53%
Cap/Depr(5y)213.76%
Cap/Sales(3y)2.09%
Cap/Sales(5y)1.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-837.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-741.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.2%
Revenue growth 3Y8.74%
Revenue growth 5Y15.24%
Sales Q2Q%6.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-481.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.93%
OCF growth 3YN/A
OCF growth 5YN/A